Literature DB >> 7898384

Characterization of a Chlamydia pneumoniae strain isolated from a 57-year-old man.

N Miyashita1, Y Kubota, M Kimura, M Nakajima, Y Niki, R Soejima, A Matsumoto.   

Abstract

The isolation of Chlamydia pneumoniae, especially from elderly persons, is generally not easy. Recently, we succeeded in isolating a chlamydial strain, which was designated KKpn-15, from a 57-year-old man suffering from acute bronchitis. It was compared with well established strains of C. pneumoniae, C. trachomatis and C. psittaci, and its biological properties, such as the morphology of elementary bodies (EBs) and inclusions, and the immunochemistry of EB proteins, were investigated. Based on the results obtained in the present study, it was confirmed that the new chlamydial strain, KKpn-15, is a member of the C. pneumoniae strain and that the organisms of KKpn-15 are useful as an antigen for the serodiagnosis and epidemiology of C. pneumoniae infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7898384     DOI: 10.1111/j.1348-0421.1994.tb02138.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  4 in total

1.  Seroepidemiology of Chlamydia pneumoniae in Japan between 1991 and 2000.

Authors:  N Miyashita; H Fukano; K Yoshida; Y Niki; T Matsushima
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

2.  In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.

Authors:  N Miyashita; Y Niki; T Kishimoto; M Nakajima; T Matsushima
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

3.  Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma.

Authors:  A Matsumoto; H Izutsu; N Miyashita; M Ohuchi
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Chlamydia pneumoniae and exacerbations of asthma in adults.

Authors:  N Miyashita; Y Kubota; M Nakajima; Y Niki; H Kawane; T Matsushima
Journal:  Ann Allergy Asthma Immunol       Date:  1998-05       Impact factor: 6.347

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.